ArticleClinical and translational medicine2020

Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1.

Rui Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.